semaglutide and liver function Can Cause Damage? Safety Evidence Explained Does GLP-1 Affect Liver Enzymes?

However, the agency stressed that the finding does not change its investigation

The goal: moving away from treating obesity as a singular condition toward precision approaches based on an individual's biology

The global peptide therapeutics market was valued at nearly $50 billion in 2024, and its projected to reach up to around $84 billion by 2034.1 One of the most well-known peptides in recent years is semaglutide (Ozempic), a glucagon-like peptide-1 receptor agonist (GLP-1) used for the treatment of type 2 diabetes.2 However, semaglutide is just one of many different peptides that could potentially lead to health benefits

Although most studies on this topic rely on patient records, a small controlled clinical trial reported last month provided further evidence that GLP-1 agonists may help treat alcohol addiction